2, 3-dibromopropionate compound as well as preparation method and application thereof
By developing 2,3-dibromopropionate compounds and their preparation methods, the prevention and treatment of plant fungi diseases and drug resistance in the prior art has been solved, effective inhibition of a variety of plant pathogens has been achieved, and an environmentally friendly New plant antibacterial agent.
Patent Information
- Application Number
- CN202410976865.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-19
- Publication Date
- 2024-11-12
AI Technical Summary
The prior art is difficult to effectively prevent and treat plant fungic diseases, and the problem of drug resistance caused by long-term use of chemical fungicides has not been effectively solved.
A 2,3-dibromoblastate compound and its preparation method have good plant pathogenic fungal inhibitory activity, and the compound is prepared through specific synthesis steps for preparing plant antibacterial drugs.
This compound has good control effects on more than a dozen common plant pathogens, has a simple structure, is environmentally friendly, is safe for animals and plants, and has broad-spectrum antibacterial activity. It is suitable as a new type of plant antibacterial agent.
Smart Images

Figure CN118930434A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of organic compound synthesis, and in particular to a 2,3-dibromopropionic acid ester compound and a preparation method and application thereof. Background Art
[0002] Plant fungal diseases are a global problem that affects crop yield and quality. Some plant pathogenic fungi also produce mycotoxins that are harmful to humans and mammals, leading to food safety issues. At the same time, there are many types of plant pathogenic fungi, and plant diseases caused by them account for about 2 / 3 of plant diseases. Therefore, the prevention and control of plant fungal diseases is one of the important aspects of plant protection.
[0003] Chemical fungicides have always been the main means of preventing and controlling plant fungal diseases. However, the long-term use of any chemical fungicide will lead to the emergence of resistance. Therefore, replacing pesticide varieties that have developed resistance or do not meet the requirements of modern pesticides with new pesticide varieties has always been the main direction of pesticide development.
[0004] 3-phenyl-2,3-dibromopropionate compounds can be regarded as derivatives of cinnamate compounds reacted with bromine. There are many reports on the synthesis of this type of compound, but few studies on its biological activity. Bratt K et al. isolated 3-phenyl-2,3-dibromopropionic acid ethyl ester from larch bark and proved that it has antifeedant activity against pine weevils (J. Chem. Ecol. 2001, 27 (11), 2253-2262). Vale J Ado et al. reported the anticancer activity of 3-phenyl-2,3-dibromopropionic acid phenyl ester (Biomed. Pharmacother. 2022, 148, 112689). So far, there are no reports on the inhibitory activity of 3-phenyl-2,3-dibromopropionate compounds or analogs specifically against plant pathogenic fungi. Summary of the invention
[0005] In order to solve the problems existing in the prior art, the present invention provides a 2,3-dibromopropionate compound and a preparation method and application thereof. The 2,3-dibromopropionate compound provided by the present invention has good plant pathogenic fungi inhibitory activity.
[0006] In order to achieve the above objectives, the present invention provides the following technical solutions.
[0007] The present invention provides a 2,3-dibromopropionic acid ester compound having a structure shown in Formula I-1, Formula I-3 or Formula I-3:
[0008]
[0009] The formula I-1 includes compound a, compound b or compound c;
[0010] In the compound a, R is hydrogen, and R' is methyl, propyl, isopropyl or n-butyl;
[0011] In the compound b, when R is hydrogen, 2-fluoro, 3-fluoro, 4-fluoro, 2-chloro, 3-chloro, 4-chloro, 2-bromo, 3-bromo, 4-bromo, 2-trifluoromethyl, 3-trifluoromethyl, 4-trifluoromethyl, 2-cyano, 3-cyano, 4-cyano, 2-nitro, 3-nitro, 4-nitro, 2-methyl, 3-methyl, 4-methyl, 2,3-difluoro, 2,4-difluoro, 2,5-difluoro, 2,6-difluoro, 3,4-difluoro, 3,5-difluoro, 2-fluoro-3-chloro, 2-fluoro-5-chloro, 2-fluoro-6-chloro, 3-fluoro-2-chloro, 3-fluoro-4-chloro, 5-fluoro-2-nitro, 5-chloro-2-nitro or 5-bromo-2-nitro, R' is ethyl;
[0012] In compound c, when R is 2-methoxy, 3-methoxy or 4-ethyl, R' is ethyl.
[0013] The present invention also provides a method for preparing the 2,3-dibromopropionic acid ester compound described in the above technical solution.
[0014] When the 2,3-dibromopropionic acid ester compound is compound a, the preparation method comprises the following steps:
[0015] After mixing cinnamic acid, dichloromethane and dichlorothionyl, a first substitution reaction is carried out, and the obtained reaction solution is mixed with an alcohol solution having a structure of formula A, and a second substitution reaction is carried out to obtain compound B;
[0016] R'OH formula A;
[0017] The compound B and the hydrobromic acid solution are dissolved in chloroform, and a first addition reaction is carried out under the initiation of tert-butyl hydroperoxide to obtain compound a;
[0018] When the 2,3-dibromopropionic acid ester compound is compound b, the preparation method comprises the following steps:
[0019] Ethyl 2-bromoacetate and triphenylphosphine are dissolved in ethyl acetate to carry out a nucleophilic substitution reaction to obtain compound C;
[0020]
[0021] Dissolving the compound C and the benzaldehyde compound having the structure of formula D in anhydrous ethanol, and performing a Wittig reaction to obtain a compound E;
[0022] The compound E and the hydrobromic acid solution are dissolved in chloroform, and a second addition reaction is carried out under the initiation of tert-butyl hydroperoxide to obtain compound b;
[0023] When the 2,3-dibromopropionic acid ester compound is compound c, the preparation method comprises the following steps:
[0024] Dissolving the compound E and bromine in chloroform, and performing a third addition reaction to obtain compound c;
[0025] When the 2,3-dibromopropionic acid ester compound is compound I-2 or I-3, the preparation method comprises the following steps:
[0026] Dissolving the compound C and 2-pyridinecarboxaldehyde or 3-pyridinecarboxaldehyde in anhydrous ethanol, and performing a third substitution reaction to obtain a compound F;
[0027]
[0028] The compound F and bromine are dissolved in chloroform and subjected to a fourth addition reaction to obtain compound I-2 or I-3.
[0029] Preferably, the molar ratio of the cinnamic acid to thionyl chloride is 1:1.5-3.0; the molar ratio of the cinnamic acid to alcohol is 1:1.4-2.0;
[0030] The first substitution reaction is carried out at 40-50°C and the insulation time is 3-5h;
[0031] The temperature of the second substitution reaction is room temperature, and the time is 2 to 3 hours.
[0032] Preferably, the molar ratio of the compound B, the hydrobromic acid in the hydrobromic acid solution and tert-butyl hydroperoxide is 1:2-2.8:2-2.8;
[0033] The temperature of the first addition reaction is 62-65° C., and the time is preferably 5-24 hours.
[0034] Preferably, the molar ratio of ethyl 2-bromoacetate to triphenylphosphine is 1:1 to 1.4.
[0035] Preferably, the temperature of the nucleophilic substitution reaction is room temperature, and the time is 2 to 5 hours.
[0036] Preferably, the molar ratio of the compound C to the benzaldehyde compound is 1:1-1.2; the temperature of the wittig reaction is 60-90° C.; and the insulation time is 2-4 hours.
[0037] Preferably, the molar ratio of the compound E to bromine is 1:1.2-1.4; the temperature of the third addition reaction is 0-30° C.; and the time is 2-5 hours.
[0038] The present invention also provides the use of the 2,3-dibromopropionate compounds described in the above technical scheme or the 2,3-dibromopropionate compounds prepared by the preparation method described in the above technical scheme as antibacterial active ingredients in the preparation of plant antibacterial drugs.
[0039] Preferably, the plant antibacterial drug has preventive and therapeutic effects on plant diseases caused by plant pathogenic fungi; the plant pathogenic fungi include one or more of melon powdery mildew, grape downy mildew, cotton wilt, watermelon wilt, potato dry rot, wheat fusarium, tomato early blight, cabbage black spot, tobacco brown spot, corn curvature, apple anthracnose, pumpkin wilt, apple rot, rice blast and apple ring rot.
[0040] The 2,3-dibromopropionic acid ester compound provided by the present invention has a structure shown in Formula I-1, Formula I-3 or Formula I-3:
[0041]
[0042] The formula I-1 includes compound a, compound b or compound c; in the compound a, R is hydrogen, R' is methyl, propyl, isopropyl or n-butyl; in the compound b, R is hydrogen, 2-fluoro, 3-fluoro, 4-fluoro, 2-chloro, 3-chloro, 4-chloro, 2-bromo, 3-bromo, 4-bromo, 2-trifluoromethyl, 3-trifluoromethyl, 4-trifluoromethyl, 2-cyano, 3-cyano, 4-cyano, 2-nitro, 3-nitro, 4-nitro, 2-methyl, 3- When R' is 2-methoxy, 3-methoxy or 4-ethyl in compound c, R' is ethyl.
[0043] The 2,3-dibromopropionate compounds involved in the present invention have the following advantages: simple structure, strong antibacterial activity, broad antibacterial spectrum, and good control effect on more than ten common plant pathogens; this type of compound is a natural compound or a derivative or analog of a natural compound, is environmentally friendly, and highly safe for animals and plants, and has great potential as a new type of plant antibacterial agent. DETAILED DESCRIPTION
[0044] The present invention provides a 2,3-dibromopropionic acid ester compound having a structure shown in Formula I-1, Formula I-3 or Formula I-3:
[0045]
[0046] The formula I-1 includes compound a, compound b or compound c;
[0047] In the compound a, R is hydrogen, and R' is methyl, propyl, isopropyl or n-butyl;
[0048] In the compound b, when R is hydrogen, 2-fluoro, 3-fluoro, 4-fluoro, 2-chloro, 3-chloro, 4-chloro, 2-bromo, 3-bromo, 4-bromo, 2-trifluoromethyl, 3-trifluoromethyl, 4-trifluoromethyl, 2-cyano, 3-cyano, 4-cyano, 2-nitro, 3-nitro, 4-nitro, 2-methyl, 3-methyl, 4-methyl, 2,3-difluoro, 2,4-difluoro, 2,5-difluoro, 2,6-difluoro, 3,4-difluoro, 3,5-difluoro, 2-fluoro-3-chloro, 2-fluoro-5-chloro, 2-fluoro-6-chloro, 3-fluoro-2-chloro, 3-fluoro-4-chloro, 5-fluoro-2-nitro, 5-chloro-2-nitro or 5-bromo-2-nitro, R' is ethyl;
[0049] In compound c, when R is 2-methoxy, 3-methoxy or 4-ethyl, R' is ethyl.
[0050] The present invention also provides a method for preparing the 2,3-dibromopropionate compound described in the above technical solution. When the 2,3-dibromopropionate compound is compound a, the preparation method comprises the following steps:
[0051] After mixing cinnamic acid, dichloromethane and dichlorothionyl, a first substitution reaction is carried out, and the obtained reaction solution is mixed with an alcohol solution having a structure of formula A, and a second substitution reaction is carried out to obtain compound B;
[0052] R'OH formula A;
[0053] The compound B and the hydrobromic acid solution are dissolved in chloroform, and a first addition reaction is carried out under the initiation of tert-butyl hydroperoxide to obtain compound a.
[0054] In the present invention, cinnamic acid, dichloromethane and thionyl chloride are mixed, and then a first substitution reaction is carried out. The obtained reaction solution is mixed with an alcohol solution having a structure of formula A, and then a second substitution reaction is carried out to obtain compound B.
[0055] In the present invention, the step of cinnamic acid, alcohol, thionyl chloride and dichloromethane is preferably:
[0056] Cinnamic acid was dissolved in dichloromethane, and thionyl chloride was added dropwise under stirring at room temperature. The resulting solution was heated to reflux, and then alcohol was added under ice-water bath conditions.
[0057] In the present invention, the molar ratio of cinnamic acid to thionyl chloride is preferably 1:1.5-3.0, more preferably 1:1.4; the molar ratio of cinnamic acid to alcohol is preferably 1:1.4-2.0, more preferably 1:2.0; the amount ratio of cinnamic acid to dichloromethane is preferably 1.0 mmol:1-3 mL, more preferably 1.0 mmol:2.0 mL.
[0058] In the present invention, the first substitution reaction is preferably a heating reflux substitution; the temperature of the heating reflux substitution is preferably 40 to 50° C., more preferably 45° C.; the time is preferably 3 to 5 hours, more preferably 4 hours.
[0059] In the present invention, the second substitution reaction is preferably carried out under stirring conditions, and the stirring time is preferably 2 to 4 hours.
[0060] After obtaining compound B, the present invention dissolves the compound B and hydrobromic acid solution in chloroform, and performs a first addition reaction under the initiation of tert-butyl hydroperoxide to obtain compound a.
[0061] In the present invention, the tert-butyl hydroperoxide is preferably used in the form of an aqueous solution of tert-butyl hydroperoxide; the mass concentration of the aqueous solution of tert-butyl hydroperoxide is preferably 70%; the mass concentration of the hydrobromic acid solution is preferably 40-50%, more preferably 47%.
[0062] In the present invention, the molar ratio of the compound B, the hydrobromic acid in the hydrobromic acid solution and tert-butyl hydroperoxide is preferably 1:2-2.8:2-2.8, more preferably 1:2.4:2.4.
[0063] In the present invention, the step of mixing and dissolving the compound B, the hydrobromic acid solution, the tert-butyl hydroperoxide aqueous solution and chloroform is preferably:
[0064] Compound B was dissolved in chloroform, and under stirring in an ice-water bath, a hydrobromic acid solution was added, and a tert-butyl hydroperoxide aqueous solution was added dropwise.
[0065] In the present invention, the temperature of the first addition reaction is preferably 62-65° C., more preferably 62° C., and the insulation time is preferably 5-24 h, more preferably 18 h.
[0066] In the present invention, after the first addition reaction, the method preferably further comprises diluting the obtained first addition reaction system with chloroform, washing with a 20wt.% sodium bisulfite solution, washing with water and washing with saturated brine, and drying with anhydrous sodium sulfate in sequence; the organic phase obtained by drying is evaporated under reduced pressure to remove the solvent, and the obtained residue is separated by silica gel column chromatography using petroleum ether-ethyl acetate as an eluent; the volume ratio of petroleum ether to ethyl acetate in the petroleum ether-ethyl acetate is preferably 20:1.
[0067] When the 2,3-dibromopropionic acid ester compound is compound b, the preparation method comprises the following steps:
[0068] Ethyl 2-bromoacetate and triphenylphosphine are dissolved in ethyl acetate to carry out a nucleophilic substitution reaction to obtain compound C;
[0069] Dissolving the compound C and the benzaldehyde compound having the structure of formula D in anhydrous ethanol, and performing a Wittig reaction to obtain a compound E;
[0070]
[0071] The compound E and the hydrobromic acid solution are dissolved in chloroform, and a second addition reaction is carried out under the initiation of tert-butyl hydroperoxide to obtain compound b.
[0072] The present invention dissolves ethyl 2-bromoacetate and triphenylphosphine in ethyl acetate, and performs a nucleophilic substitution reaction to obtain compound C.
[0073] In the present invention, the molar ratio of ethyl 2-bromoacetate to triphenylphosphine is preferably 1:1 to 1.4, more preferably 1:1 to 1.2. In the present invention, the amount ratio of triphenylphosphine to ethyl acetate is preferably 1 mmol:2 to 2.5 mL, more preferably 1 mmol:2 mL.
[0074] In the present invention, the step of dissolving ethyl 2-bromoacetate and triphenylphosphine in ethyl acetate is preferably:
[0075] Triphenylphosphine was dissolved in ethyl acetate and stirred at room temperature, and ethyl 2-bromoacetate was slowly added dropwise to the resulting mixed solution.
[0076] In the present invention, the temperature of the nucleophilic substitution reaction is preferably room temperature, and the time is preferably 2 to 5 hours, more preferably 3 hours.
[0077] In the present invention, after the nucleophilic substitution reaction, it is preferred that the system obtained by the nucleophilic substitution reaction is subjected to vacuum filtration to obtain a solid phase; the obtained solid phase is sequentially washed with ethyl acetate and extracted, and the organic phase obtained by extraction is sequentially washed with water and saturated brine, dried and filtered, and the obtained solution is decompressed to remove the solvent to obtain a yellow solid; the yellow solid is recrystallized with a mixed solution of ethyl acetate and dichloromethane. In the present invention, the extraction is preferably performed by mixing the solid phase, ethyl acetate-dichloromethane and sodium hydroxide solution for extraction; the volume ratio of ethyl acetate to dichloromethane in the ethyl acetate-dichloromethane is preferably 3:1; the mass concentration of the sodium hydroxide solution is preferably 20%.
[0078] After obtaining compound C, the present invention dissolves compound C and a benzaldehyde compound having a structure of formula D in anhydrous ethanol and performs a wittig reaction to obtain compound E.
[0079] In the present invention, the molar ratio of the compound C to the benzaldehyde compound is preferably 1:1.0-1.2, more preferably 1:1.2. In the present invention, the usage ratio of the compound C to anhydrous ethanol is preferably 1 mmol:5-10 mL, more preferably 1 mmol:7 mL.
[0080] In the present invention, the temperature of the wittig reaction is preferably 60-90° C., more preferably 80° C., and the insulation time is preferably 2-4 h, more preferably 3 h.
[0081] In the present invention, after the wittig reaction, the method preferably further comprises distilling off the solvent from the system obtained by the wittig reaction under reduced pressure, and subjecting the obtained residue to silica gel column chromatography; the eluent of the silica gel column chromatography is preferably petroleum ether-ethyl acetate; the volume ratio of the petroleum ether to ethyl acetate is preferably 20:1.
[0082] After obtaining compound D, the present invention dissolves the compound D and hydrobromic acid solution in chloroform, and conducts a second addition reaction under the initiation of tert-butyl hydroperoxide to obtain compound b.
[0083] In the present invention, the tert-butyl hydroperoxide is preferably used in the form of an aqueous solution of tert-butyl hydroperoxide. In the present invention, the molar ratio of the compound D, the hydrobromic acid solution and the tert-butyl hydroperoxide is preferably 1:2-2.8:2-2.8, more preferably 1:2.4:2.4.
[0084] In the present invention, the molar ratio of the compound D, the hydrobromic acid in the hydrobromic acid solution and tert-butyl hydroperoxide is preferably 1:2-2.8:2-2.8, more preferably 1:2.4:2.4.
[0085] Compound D is dissolved in chloroform, and under stirring in an ice-water bath, a hydrobromic acid solution is added, and a tert-butyl hydroperoxide aqueous solution is added dropwise. In the present invention, the mass concentration of the hydrobromic acid solution is preferably 40-50%, more preferably 47%; the mass concentration of the tert-butyl hydroperoxide aqueous solution is preferably 70%.
[0086] In the present invention, the temperature, time and post-treatment process of the second addition reaction are preferably the same as those of the first addition reaction, which will not be described in detail herein.
[0087] When the 2,3-dibromopropionic acid ester compound is compound c, the preparation method comprises the following steps:
[0088] Dissolving the compound E and bromine in chloroform, and performing a third addition reaction to obtain compound c;
[0089] In the present invention, the step of dissolving compound E and bromine in chloroform is preferably:
[0090] Compound E was dissolved in chloroform, and then bromine was added dropwise to the resulting mixture under ice-salt bath and stirring conditions.
[0091] In the present invention, the molar ratio of the compound E to bromine is preferably 1:1.2-1.4, more preferably 1:1.2.
[0092] In the present invention, the temperature of the third addition reaction is preferably 0 to 30° C., more preferably 0 to 5° C.; the time is preferably 2 to 5 hours, more preferably 3 hours.
[0093] In the present invention, the post-treatment process of the third addition reaction is preferably the same as the first addition reaction, which will not be described in detail here.
[0094] When the 2,3-dibromopropionic acid ester compound is compound I-2 or I-3, the preparation method comprises the following steps:
[0095] Dissolving the compound C and 2-pyridinecarboxaldehyde or 3-pyridinecarboxaldehyde in anhydrous ethanol, and performing a third substitution reaction to obtain a compound F;
[0096]
[0097] The compound F and bromine are dissolved in chloroform and subjected to a fourth addition reaction to obtain compound I-2 or I-3.
[0098] In the present invention, the compound C and 2-pyridinecarboxaldehyde or 3-pyridinecarboxaldehyde are dissolved in anhydrous ethanol, and a third substitution reaction is performed to obtain compound F.
[0099] In the present invention, the molar ratio of the compound C and 2-pyridinecarboxaldehyde or 3-pyridinecarboxaldehyde is preferably 1-1.5:1, more preferably 1-1.4:1; in the present invention, the usage ratio of the compound C and anhydrous ethanol is preferably 1mmol:2-5mL, more preferably 1mmol:3mL.
[0100] In the present invention, the temperature of the third substitution reaction is preferably 60-85° C., more preferably 80° C., and the insulation time is preferably 2-4 h, more preferably 3 h.
[0101] In the present invention, after the third substitution reaction, the method preferably further comprises distilling the solvent from the system obtained by the third substitution reaction under reduced pressure, and subjecting the obtained residue to silica gel column chromatography; the eluent of the silica gel column chromatography is preferably petroleum ether-ethyl acetate; the volume ratio of petroleum ether to ethyl acetate is preferably 20:1.
[0102] After obtaining compound F, the present invention dissolves compound F and bromine in chloroform to carry out a fourth addition reaction to obtain compound I-2 or I-3.
[0103] In the present invention, the molar ratio of the compound F to bromine is preferably 1:1 to 1.2, more preferably 1:1.
[0104] In the present invention, the temperature of the fourth addition reaction is preferably -10 to 25°C, more preferably -5°C; the time is preferably 2 to 5 hours, more preferably 3 hours.
[0105] In the present invention, after the fourth addition reaction, it is preferred that the system obtained by the fourth addition reaction is diluted with chloroform, and then washed with 20wt.% sodium bisulfite solution, water and saturated brine in sequence, and the obtained organic phase is dried with anhydrous sodium sulfate. Then, the solvent is evaporated under reduced pressure, and the obtained residue is subjected to silica gel column chromatography, and the eluent of the silica gel column chromatography is preferably petroleum ether-ethyl acetate; the volume ratio of petroleum ether to ethyl acetate in the petroleum ether-ethyl acetate is preferably 40:1.
[0106] The preparation method of the 2,3-dibromopropionic ester compound provided by the present invention has few synthetic steps, a simple preparation process, is environmentally friendly, and is suitable for large-scale production; the reaction yield is high, and the product purification method is simple.
[0107] The present invention also provides the use of the 2,3-dibromopropionate compounds described in the above technical scheme or the 3-dibromopropionate compounds prepared by the above preparation method as antibacterial active ingredients in the preparation of plant antibacterial drugs.
[0108] In the present invention, the plant antibacterial drug preferably has preventive and therapeutic effects on plant diseases caused by plant pathogenic fungi; the plant pathogenic fungi preferably include one or more of melon powdery mildew, grape downy mildew, cotton wilt, watermelon wilt, potato dry rot, wheat fusarium, tomato early blight, cabbage black spot, tobacco brown spot, corn curvature, apple anthracnose, pumpkin wilt, apple rot, rice blast and apple ring rot.
[0109] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0110] Example 1 - Compound 1: Preparation of methyl 3-phenyl-2,3-dibromopropionate:
[0111] Dissolve 5 mmol of cinnamic acid in 10 mL of dry dichloromethane, then add 15 mmol of thionyl chloride. Heat the resulting solution to reflux (temperature 45°C) for 3 hours, place the reaction bottle in an ice-water bath, and add 7 mmol of methanol under stirring. Stir the resulting solution at room temperature for about 2 hours until the reaction is complete.
[0112] The reaction solution was concentrated under reduced pressure to remove dichloromethane and remaining thionyl chloride. Then, 10 mL of chloroform was added to the residue. Under ice-water bath and stirring conditions, 40 wt% hydrobromic acid solution (12 mmol HBr) was added thereto, followed by dropwise addition of 70% tert-butyl hydroperoxide (containing 12 mmol TBHP). The resulting solution was first stirred at room temperature for 30 min, then heated to reflux (temperature 62° C.) for 10 h until the reaction was complete.
[0113] 50 mL of chloroform was added to the reaction system, and then washed with 20 wt.% sodium bisulfite solution, water and saturated brine, respectively, and finally the organic phase was dried over anhydrous sodium sulfate. After the solvent was evaporated under reduced pressure, the obtained residue was separated by silica gel column chromatography using petroleum ether-ethyl acetate (20:1, v / v) as the eluent to obtain compound 1.
[0114] Example 2 - Compound 2: Preparation of ethyl 3-phenyl-2,3-dibromopropionate:
[0115] 6mmol of triphenylphosphine was dissolved in 10mL of ethyl acetate. Stirring at room temperature, 5mmol of ethyl 2-bromoacetate was slowly added thereto. After addition, stirring was continued for 2h. Then, the reaction system was filtered under reduced pressure and the solid was fully washed with ethyl acetate. The washed solid was added to a mixed solution of 12mL of ethyl acetate and dichloromethane (3:1, v / v). Under stirring at room temperature, 20wt% of sodium hydroxide solution was slowly added until the solid was completely dissolved. 40mL of ethyl acetate was added to the reaction solution, the resulting solution was transferred to a separatory funnel, the organic phase was collected, and washed once with water and saturated brine, and finally dried over anhydrous sodium sulfate. After filtration, the resulting solution was evaporated under reduced pressure to remove the solvent to obtain a yellow solid. The yellow solid was recrystallized with a mixed solvent of ethyl acetate and dichloromethane to obtain a white solid, i.e., triphenylphosphine ylide (Compound C).
[0116] The triphenylphosphine ylide obtained above was dissolved in 40 mL of anhydrous ethanol. Stirring at room temperature, 5 mmol of benzaldehyde was slowly added dropwise. After the addition was completed, the mixture was heated to reflux at 80°C for 3 h, and the reaction was complete. The solvent was evaporated under reduced pressure, and the obtained residue was subjected to silica gel column chromatography, with petroleum ether-ethyl acetate (20:1, v / v) as the eluent, to obtain ethyl cinnamate (Compound E).
[0117] Dissolve the ethyl cinnamate obtained above in 10 mL of chloroform. Stir under ice-water cooling, add 40% hydrobromic acid solution (containing 12 mmol HBr), and then slowly drop 70% tert-butyl hydroperoxide (containing 12 mmol TBHP). After the addition, stir at room temperature for half an hour, and then heat under reflux (temperature is 62°C) for 10 hours until the reaction is complete.
[0118] 40 mL of chloroform was added to the reaction system, and then washed with 20 wt.% sodium bisulfite solution, water and saturated brine, respectively, and finally the organic phase was dried over anhydrous sodium sulfate. After the solvent was evaporated under reduced pressure, the obtained residue was subjected to silica gel column chromatography using petroleum ether-ethyl acetate (20:1, v / v) as the eluent to obtain compound 2.
[0119] Example 3---Compound 3: Preparation of 3-phenyl-2,3-dibromopropionic acid propyl ester:
[0120] The only difference from Example 1 is that methanol is replaced by propanol.
[0121] Example 4---Compound 4: Preparation of 3-phenyl-2,3-dibromopropionic acid isopropyl ester:
[0122] The only difference from Example 1 is that methanol is replaced by isopropanol.
[0123] Example 5---Compound 5: Preparation of 3-phenyl-2,3-dibromopropionic acid n-butyl ester:
[0124] The only difference from Example 1 is that methanol is replaced by n-butanol.
[0125] Example 6---Compound 6: Preparation of ethyl 3-(2-fluorophenyl)-2,3-dibromopropionate:
[0126] The only difference from Example 2 is that benzaldehyde is replaced by 2-fluorobenzaldehyde.
[0127] Example 7 - Compound 7: Preparation of ethyl 3-(3-fluorophenyl)-2,3-dibromopropionate:
[0128] The only difference from Example 2 is that benzaldehyde is replaced by 3-fluorobenzaldehyde.
[0129] Example 8 - Compound 8: Preparation of ethyl 3-(4-fluorophenyl)-2,3-dibromopropionate:
[0130] The only difference from Example 2 is that benzaldehyde is replaced by 4-fluorobenzaldehyde.
[0131] Example 9---Compound 9: Preparation of ethyl 3-(2-chlorophenyl)-2,3-dibromopropionate:
[0132] The only difference from Example 2 is that benzaldehyde is replaced by 2-chlorobenzaldehyde.
[0133] Example 10 - Compound 10: Preparation of ethyl 3-(3-chlorophenyl)-2,3-dibromopropionate:
[0134] The only difference from Example 2 is that benzaldehyde is replaced by 3-chlorobenzaldehyde.
[0135] Example 11 - Compound 11: Preparation of ethyl 3-(4-chlorophenyl)-2,3-dibromopropionate:
[0136] The only difference from Example 2 is that benzaldehyde is replaced by 4-chlorobenzaldehyde.
[0137] Example 12 - Compound 12: Preparation of ethyl 3-(2-bromophenyl)-2,3-dibromopropionate:
[0138] The only difference from Example 2 is that benzaldehyde is replaced by 2-bromobenzaldehyde.
[0139] Example 13 - Compound 13: Preparation of ethyl 3-(3-bromophenyl)-2,3-dibromopropionate:
[0140] The only difference from Example 2 is that benzaldehyde is replaced by 3-bromobenzaldehyde.
[0141] Example 14 - Compound 14: Preparation of ethyl 3-(4-bromophenyl)-2,3-dibromopropionate:
[0142] The only difference from Example 2 is that benzaldehyde is replaced by 4-bromobenzaldehyde.
[0143] Example 15 - Compound 15: Preparation of ethyl 3-(2-trifluoromethyl)phenyl-2,3-dibromopropionate:
[0144] The only difference from Example 2 is that benzaldehyde is replaced by 2-trifluoromethylbenzaldehyde.
[0145] Example 16 - Compound 16: Preparation of ethyl 3-(3-trifluoromethyl)phenyl-2,3-dibromopropionate:
[0146] The only difference from Example 2 is that benzaldehyde is replaced by 3-trifluoromethylbenzaldehyde.
[0147] Example 17 - Compound 17: Preparation of ethyl 3-(4-trifluoromethyl)phenyl-2,3-dibromopropionate:
[0148] The only difference from Example 2 is that benzaldehyde is replaced by 4-trifluoromethylbenzaldehyde.
[0149] Example 18 - Compound 18: Preparation of ethyl 3-(2-cyanophenyl)-2,3-dibromopropionate:
[0150] The only difference from Example 2 is that benzaldehyde is replaced by 2-cyanobenzaldehyde.
[0151] Example 19 - Compound 19: Preparation of ethyl 3-(3-cyanophenyl)-2,3-dibromopropionate:
[0152] The only difference from Example 2 is that benzaldehyde is replaced by 3-cyanobenzaldehyde.
[0153] Example 20 - Compound 20: Preparation of ethyl 3-(4-cyanophenyl)-2,3-dibromopropionate:
[0154] The only difference from Example 2 is that benzaldehyde is replaced by 4-cyanobenzaldehyde.
[0155] Example 21 - Compound 21: Preparation of ethyl 3-(2-nitrophenyl)-2,3-dibromopropionate:
[0156] The only difference from Example 2 is that benzaldehyde is replaced by 2-nitrobenzaldehyde.
[0157] Example 22 - Compound 22: Preparation of ethyl 3-(3-nitrophenyl)-2,3-dibromopropionate:
[0158] The only difference from Example 2 is that benzaldehyde is replaced by 3-nitrobenzaldehyde.
[0159] Example 23 - Compound 23: Preparation of ethyl 3-(4-nitrophenyl)-2,3-dibromopropionate:
[0160] The only difference from Example 2 is that benzaldehyde is replaced by 4-nitrobenzaldehyde.
[0161] Example 24 - Compound 24: Preparation of ethyl 3-(2-methylphenyl)-2,3-dibromopropionate:
[0162] The only difference from Example 2 is that benzaldehyde is replaced by 2-methylbenzaldehyde.
[0163] Example 25 - Compound 25: Preparation of ethyl 3-(3-methylphenyl)-2,3-dibromopropionate:
[0164] The only difference from Example 2 is that benzaldehyde is replaced by 3-methylbenzaldehyde.
[0165] Example 26 - Compound 26: Preparation of ethyl 3-(4-methylphenyl)-2,3-dibromopropionate:
[0166] The only difference from Example 2 is that benzaldehyde is replaced by 4-methylbenzaldehyde.
[0167] Example 27 - Compound 27: Preparation of ethyl 3-(2-methoxyphenyl)-2,3-dibromopropionate:
[0168] 6 mmol of triphenylphosphine was dissolved in 10 mL of ethyl acetate. The mixture was stirred at room temperature, and 5 mmol of ethyl 2-bromoacetate was slowly added dropwise thereto. After the addition was complete, the mixture was stirred for 2 h.
[0169] The reaction system was then filtered under reduced pressure, and the solid was fully washed with ethyl acetate, and the washed solid was added to a mixed solution of 12 mL of ethyl acetate and dichloromethane (3:1, v / v). Stir at room temperature and slowly add 20 wt.% sodium hydroxide solution until the solid was completely dissolved. 40 mL of ethyl acetate was added to the reaction solution, and the resulting solution was transferred to a separatory funnel, the organic phase was collected, and washed once with water and saturated brine, and finally dried over anhydrous sodium sulfate. After filtration, the resulting solution was evaporated under reduced pressure to remove the solvent to obtain a yellow solid. The yellow solid was recrystallized from a mixed solvent of ethyl acetate and dichloromethane to obtain a white solid, i.e., triphenylphosphine ylide (compound C);
[0170] Dissolve the above-obtained 7 mmol of triphenylphosphine ylide in 40 mL of anhydrous ethanol. Stir at room temperature and slowly add 5 mmol of 2-methoxybenzaldehyde. After addition, heat and reflux at 80°C for 3 hours until the reaction is complete. Evaporate the solvent under reduced pressure, and perform silica gel column chromatography on the residue using petroleum ether-ethyl acetate (20:1, v / v) as the eluent to obtain ethyl 3-(2-methoxyphenyl) propionate (Compound E).
[0171] The obtained 5mmol 3-(2-methoxyphenyl)ethyl propionate was dissolved in 10mL chloroform. Under ice-salt bath cooling and stirring, 6mmol bromine was slowly added dropwise through a dropping funnel, and the addition was completed in 0.5h. After the addition, stirring was continued for 3h until the reaction was complete. Then, 40mL chloroform was added to the reaction system, and then washed once with 20wt.% sodium bisulfite solution, water and saturated brine respectively, and finally the organic phase was dried over anhydrous sodium sulfate. After the solvent was evaporated under reduced pressure, the obtained residue was subjected to silica gel column chromatography, and petroleum ether-ethyl acetate (20:1, v / v) was used as eluent to obtain compound 27.
[0172] Example 28 - Compound 28: Preparation of ethyl 3-(3-methoxyphenyl)-2,3-dibromopropionate:
[0173] The only difference from Example 27 is that 2-methoxybenzaldehyde is replaced by 3-methoxybenzaldehyde.
[0174] Example 29 - Compound 29: Preparation of ethyl 3-(4-ethylphenyl)-2,3-dibromopropionate:
[0175] The only difference from Example 27 is that 2-methoxybenzaldehyde is replaced by 4-ethylbenzaldehyde.
[0176] Example 30 - Compound 30: Preparation of ethyl 3-(2,3-difluorophenyl)-2,3-dibromopropionate:
[0177] The only difference from Example 2 is that benzaldehyde is replaced by 2,3-difluorobenzaldehyde.
[0178] Example 31 - Compound 31: Preparation of ethyl 3-(2,4-difluorophenyl)-2,3-dibromopropionate:
[0179] The only difference from Example 2 is that benzaldehyde is replaced by 2,4-difluorobenzaldehyde.
[0180] Example 32 - Compound 32: Preparation of ethyl 3-(2,5-difluorophenyl)-2,3-dibromopropionate:
[0181] The only difference from Example 2 is that benzaldehyde is replaced by 2,5-difluorobenzaldehyde.
[0182] Example 33 - Compound 33: Preparation of ethyl 3-(2,6-difluorophenyl)-2,3-dibromopropionate:
[0183] The only difference from Example 2 is that benzaldehyde is replaced by 2,6-difluorobenzaldehyde.
[0184] Example 34 - Compound 34: Preparation of ethyl 3-(3,4-difluorophenyl)-2,3-dibromopropionate:
[0185] The only difference from Example 2 is that benzaldehyde is replaced by 3,4-difluorobenzaldehyde.
[0186] Example 35 - Compound 35: Preparation of ethyl 3-(3,5-difluorophenyl)-2,3-dibromopropionate:
[0187] The only difference from Example 2 is that benzaldehyde is replaced by 3,5-difluorobenzaldehyde.
[0188] Example 36 - Compound 36: Preparation of ethyl 3-(2-fluoro-3-chlorophenyl)-2,3-dibromopropionate:
[0189] The only difference from Example 2 is that benzaldehyde is replaced by 2-fluoro-3-chlorobenzaldehyde.
[0190] Example 37 - Compound 37: Preparation of ethyl 3-(2-fluoro-5-chlorophenyl)-2,3-dibromopropionate:
[0191] The only difference from Example 2 is that benzaldehyde is replaced by 2-fluoro-5-chlorobenzaldehyde.
[0192] Example 38 - Compound 38: Preparation of ethyl 3-(2-fluoro-6-chlorophenyl)-2,3-dibromopropionate:
[0193] The only difference from Example 2 is that benzaldehyde is replaced by 2-fluoro-6-chlorobenzaldehyde.
[0194] Example 39 - Compound 39: Preparation of ethyl 3-(3-fluoro-2-chlorophenyl)-2,3-dibromopropionate:
[0195] The only difference from Example 2 is that benzaldehyde is replaced by 3-fluoro-2-chlorobenzaldehyde.
[0196] Example 40 - Compound 40: Preparation of ethyl 3-(3-fluoro-4-chlorophenyl)-2,3-dibromopropionate:
[0197] The only difference from Example 2 is that benzaldehyde is replaced by 3-fluoro-4-chlorobenzaldehyde.
[0198] Example 41 - Compound 41: Preparation of ethyl 3-(5-fluoro-2-nitrophenyl)-2,3-dibromopropionate:
[0199] The only difference from Example 2 is that benzaldehyde is replaced by 5-fluoro-2-nitrobenzaldehyde.
[0200] Example 42 - Compound 42: Preparation of ethyl 3-(5-chloro-2-nitrophenyl)-2,3-dibromopropionate:
[0201] The only difference from Example 2 is that benzaldehyde is replaced by 5-chloro-2-nitrobenzaldehyde.
[0202] Example 43 - Compound 43: Preparation of ethyl 3-(5-bromo-2-nitrophenyl)-2,3-dibromopropionate:
[0203] The only difference from Example 2 is that benzaldehyde is replaced by 5-bromo-2-nitrobenzaldehyde.
[0204] Example 44 - Compound 44: Preparation of ethyl 3-(2-pyridyl)-2,3-dibromopropionate:
[0205] 6 mmol of triphenylphosphine was dissolved in 10 mL of ethyl acetate. The mixture was stirred at room temperature, and 5 mmol of ethyl 2-bromoacetate was slowly added dropwise thereto. After the addition was complete, the mixture was stirred for 2 h.
[0206] The reaction system was filtered under reduced pressure, and the solid was fully washed with ethyl acetate, and then the washed solid was added to a mixed solution of 12 mL of ethyl acetate and dichloromethane (3:1, v / v). Stir at room temperature and slowly add 20 wt.% sodium hydroxide solution until the solid was completely dissolved. The reaction solution was transferred to a separatory funnel, the organic phase was collected, and washed once with water and saturated brine, and finally dried over anhydrous sodium sulfate. After filtration, the resulting solution was evaporated under reduced pressure to remove the solvent to obtain a yellow solid. The yellow solid was recrystallized from a mixed solvent of ethyl acetate and dichloromethane to obtain a white solid, i.e., triphenylphosphine ylide (compound C);
[0207] Add 7 mmol of the prepared triphenylphosphine ylide to anhydrous ethanol. Slowly add 5 mmol of 2-pyridinecarboxaldehyde under stirring at room temperature. After the addition is complete, react at 80°C for 3 hours until the reaction is complete. Evaporate the solvent under reduced pressure, and perform silica gel column chromatography on the resulting residue using petroleum ether-ethyl acetate (20:1, v / v) as the eluent to obtain 5 mmol of ethyl pyridylacrylate (Compound F);
[0208] The above-obtained 5 mmol of ethyl pyridylacrylate was dissolved in 10 mL of chloroform. Under cooling and stirring at -15°C, 6 mmol of bromine was slowly added dropwise over 0.5 h. After addition, stirring was continued for about 3 h until the reaction was complete. Then, 40 mL of chloroform was added to the reaction system, and then washed once with 20 wt.% sodium bisulfite solution, water and saturated brine in sequence, and finally the organic phase was dried over anhydrous sodium sulfate. After the solvent was evaporated under reduced pressure, the resulting residue was subjected to silica gel column chromatography using petroleum ether-ethyl acetate (40:1, v / v) as eluent to obtain compound 44.
[0209] Example 45 - Compound 45: Preparation of ethyl 3-(3-pyridyl)-2,3-dibromopropionate:
[0210] The only difference from Example 44 is that the 2-pyridinecarboxaldehyde is replaced by 3-pyridinecarboxaldehyde.
[0211] The names, physicochemical properties and NMR spectra of compounds 1 to 45 are as follows:
[0212] 3-phenyl-2,3-dibromopropionic acid methyl ester (Compound 1): Yield 81%. White solid. mp: 105.4-106.3℃. 1 HNMR(400MHz,chloroform-d)δ7.42-7.36(m,5H),5.34(d,1H),4.85(d,1H),3.90(s,3H).
[0213] 3-phenyl-2,3-dibromopropionic acid ethyl ester (Compound 2): Yield 88%. White solid. mp: 105.4-106.3℃. 1 HNMR(400MHz,chloroform-d)δ7.46-7.31(m,5H),5.34(d,1H),4.83(d,1H),4.36(q,Hz,2H),1.38(t,Hz,3H).
[0214] 3-phenyl-2,3-dibromopropionic acid propyl ester (Compound 3): Yield 74%. Light yellow liquid. 1 HNMR(400MHz,chloroform-d)δ7.42-7.34(m,5H),5.34(d,1H),4.84(d,1H),4.26(tt,2H),1.77(q,2H),1.02(t,3H).
[0215] 3-phenyl-2,3-dibromopropionic acid isopropyl ester (Compound 4): Yield 71%. White solid. mp: 46.6-47.4℃. 1 HNMR(400MHz,chloroform-d)δ7.42-7.33(m,5H),5.33(d,1H),5.19(hept,1H),4.79(d,1H),1.36(dd,6H).
[0216] 3-phenyl-2,3-dibromopropionic acid n-butyl ester (Compound 5): Yield 75%. White solid. mp: 43.5-44.2℃. 1 HNMR(400MHz,chloroform-d)δ7.43-7.35(m,5H),5.34(d,1H),4.83(d,1H),4.30(td,2H),1.79-1.69(m,2H),1.53-1.42(m,2H),0.98(t,3H).
[0217] 3-(2-Fluorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 6): Yield 85%. Light yellow liquid. 1 HNMR(400MHz,chloroform-d)δ7.42-7.32(m,2H),7.18(td,1H),7.09(ddd,1H),5.61(d,1H),4.98(d,1H),4.36(q,2H),1.37(t,3H).
[0218] 3-(3-Fluorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 7): Yield 84%. White solid. mp: 71.7-72.2°C. 1HNMR(400MHz,chloroform-d)δ7.36(td,J=8.0,5.8Hz,1H),7.23-7.16(m,1H),7.16-7.02(m,2H),5.30(d,1H),4.76(d,1H),4.36(q,2H),1.38(t,3H).
[0219] 3-(4-Fluorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 8): Yield 40%. White solid. mp: 76.2-77.2℃. 1 HNMR(400MHz,chloroform-d)δ7.42-7.37(m,2H),7.08(t,2H),5.33(d,1H),4.77(d,1H),4.36(q,2H),1.38(t,3H).
[0220] 3-(2-Chlorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 9): Yield 84%. White solid. mp: 58.2-59.2°C. 1 HNMR(400MHz,chloroform-d)δ7.50-7.45(m,1H),7.41(dd,1H),7.31(ddd,2H),5.92(s,1H),4.92(d,1H),4.37(q,2H),1.38(t,3H).
[0221] 3-(3-Chlorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 10): Yield 88.6%. White solid. mp: 70.4-71.4°C. 1 HNMR(400MHz,chloroform-d)δ7.42-7.39(m,1H),7.35-7.32(m,2H),7.31-7.27(m,1H),5.28(d,1H),4.76(d,1H),4.39-4.33(m,2H),1.37(t,3H).
[0222] 3-(4-Chlorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 11): Yield 89.5%. White solid. mp: 66.8-67.5℃. 1 HNMR(400MHz,chloroform-d)δ7.39-7.33(m,4H),5.31(d,1H),4.76(d,1H),4.36(q,2H),1.38(t,3H).
[0223] 3-(2-bromophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 12): Yield 91%. Light yellow solid. mp: 84.7-85.2°C.1 HNMR(400MHz,chloroform-d)δ7.60(dd,1H),7.48(d,1H),7.42-7.34(m,1H),7.21(ddd,1H),5.95(d,1H),4.85(d,1H),4.37(q,2H),1.38(t,3H).
[0224] 3-(3-bromophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 13): Yield 88%. White solid. mp: 80.1-81.1°C. 1 HNMR(400MHz,chloroform-d)δ7.56(t,1H),7.49(ddd,1H),7.36-7.26(m,2H),5.27(d,1H),4.76(d,1H),4.36(q,2H),1.37(t,3H).
[0225] 3-(4-bromophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 14): Yield 85.4%. White solid. mp: 71.7-72.7°C. 1 HNMR(400MHz,chloroform-d)δ7.55-7.50(m,2H),7.30-7.26(m,2H),5.30(d,1H),4.76(d,1H),4.35(q,2H),1.37(t,3H).
[0226] 3-(2-Trifluoromethyl)phenyl-2,3-dibromopropionic acid ethyl ester (Compound 15): Yield 83%. White solid. mp: 89.3-90.3°C. 1 HNMR(400MHz,chloroform-d)δ7.71-7.61(m,3H),7.50-7.44(m,1H),5.79(d,1H),4.90(d,1H),4.38(q,2H),1.38(t,3H).
[0227] 3-(3-Trifluoromethyl)phenyl-2,3-dibromopropionic acid ethyl ester (Compound 16): Yield 75%. White solid. mp: 76.6-77.0℃. 1 HNMR(400MHz,chloroform-d)δ7.68-7.58(m,3H),7.53(t,1H),5.37(d,1H),4.80(d,1H),4.40-4.34(m,2H),1.38(t,3H).
[0228] 3-(4-Trifluoromethyl)phenyl-2,3-dibromopropionic acid ethyl ester (Compound 17): Yield 89%. White solid. mp: 62.6-63.1°C. 1 HNMR(400MHz,chloroform-d)δ7.66(d,2H),7.53(d,2H),5.36(d,1H),4.80(d,1H),4.37(q,2H),1.38(t,3H).
[0229] 3-(2-Cyanophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 18): Yield 82%. White solid. mp: 93.5-93.9°C. 1 HNMR(400MHz,chloroform-d)δ7.72-7.66(m,2H),7.60(d,1H),7.49(t,1H),5.71(d,1H),4.93(s,1H),4.38(q,2H),1.39(t,3H).
[0230] 3-(3-cyanophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 19): Yield 85%. White solid. mp: 95.6-96.0℃. 1 HNMR(400MHz,chloroform-d)δ7.71(s,1H),7.68-7.63(m,2H),7.53(t,1H),5.32(d,1H),4.75(d,1H),4.37(q,2H),1.38(t,3H).
[0231] 3-(4-cyanophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 20): Yield 87%. White solid. mp: 92.5-93.1°C. 1 HNMR(400MHz,chloroform-d)δ7.70(d,2H),7.52(d,2H),5.34(d,1H),4.76(d,1H),4.37(q,2H),1.38(t,3H).
[0232] 3-(2-nitrophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 21): Yield 81%. White crystals. mp: 66.4-67.3°C. 1 HNMR(400MHz,chloroform-d)δ7.93(d,1H),7.70(d,2H),7.54(dt,1H),6.16(d,1H),4.82(d,1H),4.37(q,J=7.1Hz,2H),1.38(t,3H).
[0233] 3-(3-nitrophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 22): Yield 73%. Light yellow solid. mp: 82.8-83.1℃. 1 HNMR(400MHz,chloroform-d)δ8.32-8.21(m,2H),7.77-7.71(m,1H),7.61(t,1H),5.41(d,1H),4.81(d,1H),4.38(q,2H),1.39(t,3H).
[0234] 3-(4-nitrophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 23): Yield 79%. White crystals. mp: 108.5-109.4°C. 1 HNMR(400MHz,chloroform-d)δ8.27(d,2H),7.59(d,2H),5.39(d,1H),4.79(d,1H),4.38(q,2H),1.39(t,3H).
[0235] 3-(2-Methylphenyl)-2,3-dibromopropionic acid ethyl ester (Compound 24): Yield 51%. White solid. mp: 35.2-36.1°C. 1 HNMR (400MHz, DMSO-d6) δ7.81-7.64(m,1H),7.32-7.15(m,3H),5.61(d,2H),4.33(d,1H),4.30(d,1H),2.37(s,3H),1.29(t,3H).
[0236] 3-(3-Methylphenyl)-2,3-dibromopropionic acid ethyl ester (Compound 25): Yield 44%. White solid. mp: 84.7-85.6°C. 1 HNMR(400MHz,DMSO-d6)δ7.52-7.40(m,2H),7.27(t,1H),7.16(d,1H),5.54(d,1H),5.50(d,1H),4.30(q,2H),2.31(s,3H),1.28(t,3H).
[0237] 3-(4-Methylphenyl)-2,3-dibromopropionic acid ethyl ester (Compound 26): Yield 64%. White solid. mp: 73.0-73.6°C. 1 HNMR(400MHz,DMSO-d6)δ7.54(d,2H),7.19(d,2H),5.57(d,1H),5.51(d,1H),4.29(q,2H),2.30(s,3H),1.28(t,3H).
[0238] 3-(2-methoxyphenyl)-2,3-dibromopropionic acid ethyl ester (Compound 27): Yield 32%. White solid. mp: 110.5-111.0℃. 1 HNMR(400MHz,DMSO-d6)δ7.67(dd,1H),7.37(td,1H),7.07(d,1H),6.99(t,1H) ,5.80(d,1H),5.57(d,1H),4.38(d,1H),4.32(d,1H),3.89(s,3H),1.28(t,3H).
[0239] 3-(3-methoxyphenyl)-2,3-dibromopropionic acid ethyl ester (Compound 28): Yield 37%. White solid. mp: 53.5-54.0℃. 1 HNMR(400MHz,DMSO-d6)δ7.33-7.25(m,2H),7.21(dt,1H),6.93-6.89(m,1H),5.57(d,1H),5.53(d,1H),4.30(q,2H),3.77(s,3H),1.29(t,3H).
[0240] 3-(4-Ethylphenyl)-2,3-dibromopropionic acid ethyl ester (Compound 29): Yield 43%. White solid. mp: 85.1-86.1°C. 1 HNMR(400MHz,DMSO-d6)δ7.57(d,2H),7.23(d,2H),5.57(d,1H),5.50(d,1H),4.30(q,2H),2.61(q,2H),1.29(t,3H),1.19(t,3H).
[0241] 3-(2,3-difluorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 30): Yield 75%. Light yellow liquid. 1 HNMR(400MHz,chloroform-d)δ7.22-7.13(m,3H),5.59(d,1H),4.92(d,1H),4.37(q,2H),1.38(t,3H).
[0242] 3-(2,4-difluorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 31): Yield 67%. Light yellow liquid. 1 HNMR(400MHz,chloroform-d)δ7.39(td,1H),6.96-6.84(m,2H),5.57(d,1H),4.92(d,1H),4.36(q,2H),1.38(t,3H).
[0243] 3-(2,5-difluorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 32): Yield 58%. White solid. mp: 39.3-40.3℃. 1 HNMR(400MHz,chloroform-d)δ7.09(dddd,3H),5.55(d,1H),4.88(d,1H),4.36(q,2H),1.38(t,3H).
[0244] 3-(2,6-difluorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 33): Yield 64%. White solid. mp: 38.4-39.3°C. 1 HNMR(400MHz,chloroform-d)δ7.35(tt,1H),6.98-6.92(m,2H),5.78(d,1H),5.18(d,1H),4.36(q,2H),1.38(t,3H).
[0245] 3-(3,4-difluorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 34): Yield 62%. White solid. mp: 71.1-72.0℃. 1 HNMR (400MHz, DMSO-d6) δ7.93(ddd,1H),7.60(ddd,1H),7.48(dt,1H),5.72-5.59(m,2H),4.30(q,2H),1.29(t,3H).
[0246] 3-(3,5-difluorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 35): Yield 72%. White solid. mp: 33.8-34.8℃. 1 HNMR(400MHz,chloroform-d)δ6.99-6.91(m,2H),6.82(tt,1H),5.25(d,1H),4.70(d,1H),4.36(q,2H),1.38(t,3H).
[0247] 3-(2-Fluoro-3-chlorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 36): Yield 82%. Light yellow solid. mp: 46.6-47.4°C. 1 HNMR(400MHz,chloroform-d)δ7.43(t,1H),7.33-7.28(m,1H),7.15(t,1H),5.59(d,1H),4.92(d,1H),4.40-4.34(m,2H),1.38(td,3H).
[0248] 3-(2-Fluoro-5-chlorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 37): Yield 61%. White solid. mp: 56.0-57.0℃. 1 HNMR(400MHz,chloroform-d)δ7.38(dd,1H),7.36-7.29(m,1H),7.06(t,1H),5.52(d,1H),4.89(d,1H),4.36(q,2H),1.38(t,3H).
[0249] 3-(2-Fluoro-6-chlorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 38): Yield 72%. White solid. mp: 37.5-38.0°C. 1 HNMR(400MHz,DMSO-d6)δ7.56(td,1H),7.48(dt,1H),7.40(ddd,1H),5.90(dd,1H),5.19(d,1H),4.33(q,2H),1.29(t,3H).
[0250] 3-(3-Fluoro-2-chlorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 39): Yield 63.8%. Light yellow liquid. 1 HNMR(400MHz,chloroform-d)δ7.36-7.27(m,2H),7.17(dd,1H),5.88(brs,1H),4.86(brs,1H),4.37(q,2H),1.38(t,3H).
[0251] 3-(3-Fluoro-4-chlorophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 40): Yield 75%. White solid. mp: 50.2-51.2°C. 1 HNMR(400MHz,chloroform-d)δ7.42(t,1H),7.21(dd,1H),7.14(dd,1H),5.27(d,1H),4.71(d,1H),4.36(q,2H),1.37(t,3H).
[0252] 3-(5-Fluoro-2-nitrophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 41): Yield 53%. Light yellow solid. mp: 89.6-90.1°C. 1 HNMR(400MHz,chloroform-d)δ8.03(dd,1H),7.37(dd,1H),7.21(ddd,1H),6.23(d,1H),4.73(d,1H),4.36(q,2H),1.37(t,3H).
[0253] 3-(5-chloro-2-nitrophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 42): Yield 61%. Light yellow solid. mp: 106.3-106.9°C. 1 HNMR(400MHz,chloroform-d)δ7.92(d,1H),7.66(d,1H),7.49(dd,1H),6.18(s,1H),4.75(d,1H),4.37(q,2H),1.38(t,3H).
[0254] 3-(5-bromo-2-nitrophenyl)-2,3-dibromopropionic acid ethyl ester (Compound 43): Yield 70%. Light yellow solid. mp: 104.3-105.0℃. 1 HNMR(400MHz,chloroform-d)δ7.86-7.77(m,2H),7.65(dd,1H),6.15(brs,1H),4.75(brs,1H),4.37(q,2H),1.38(t,3H).
[0255] 3-(2-pyridyl)-2,3-dibromopropionic acid ethyl ester (Compound 44): Yield 44%. Brownish yellow solid. mp: 66.8-67.4°C. 1 HNMR(400MHz,chloroform-d)δ8.71-8.65(m,1H),7.73(td,1H),7.36(dd,1H),7.29(dd,1H),5.41(d,1H),5.24(d,1H),4.36(q,2H),1.37(t,3H).
[0256] 3-(3-pyridyl)-2,3-dibromopropionic acid ethyl ester (Compound 45): Yield 38%. Brown red solid. mp: 125.3-126.0℃. 1 HNMR(400MHz,chloroform-d)δ8.70(d,1H),8.64(dd,1H),7.84(dt,1H),7.44(dd,1H),5.37(d,1H),4.78(d,1H),4.38(q,2H),1.39(t,3H).
[0257] Application Example 1 - Determination of the in vitro antibacterial activity of compounds
[0258] The antibacterial activity was determined by the mycelial linear growth rate method.
[0259] The test bacteria are: cotton wilt pathogen, watermelon wilt pathogen, potato dry rot pathogen, wheat fusarium rust pathogen, tomato early blight pathogen, cabbage black spot pathogen, tobacco brown star pathogen, corn curvature pathogen, apple anthracnose pathogen, pumpkin wilt pathogen, apple rot pathogen, rice blast pathogen, apple ring rot pathogen. The culture medium is PDA. The test solution of the compound is prepared using 5% DMSO aqueous solution (v / v). The concentration of the test compound in the culture medium is 75μg / mL. The positive control drugs are thiabendazole and kresoxim-methyl (purity>98%). Each test is set up with three parallels each time and repeated three times. The test results are expressed as the average inhibition rate.
[0260] Application Example 2
[0261] (1) Pot test of compounds against downy mildew
[0262] The test compound was added to dimethyl sulfoxide containing 10% OP-10 to prepare a 160 mg / mL solution. Before the test, it was diluted with water to 300 μg / mL and then sprayed on the test leaves.
[0263] The test bacteria is grape downy mildew. The test was conducted by the spore germination method on leaves. The spore suspension of grape downy mildew with a spore concentration of 105 spores / ml was inoculated on the back of grape leaves by spraying. The inoculated plants were first placed in an isolation room with a high humidity environment at room temperature for 24 hours, and then the plants were transferred to a greenhouse with ambient humidity and placed at room temperature for 48 hours. Finally, the plants were transferred to a high humidity environment for 24 hours. Then, the plants were moved to a natural environment. After the water on the surface of the plants evaporated naturally, the infected leaves were removed from the plants and sprayed with 300μg / mL of the test solution. After the water on the liquid surface evaporated naturally, the petiole of the leaf was immersed in water and then placed in a high humidity environment for 72 hours. The test effect was evaluated by comparing the percentage of spore coverage area on the leaf surface of the test group and the control group.
[0264] (2) Potted plant test on resistance to powdery mildew
[0265] The test compound was added to dimethyl sulfoxide containing 10% OP-10 to prepare a 160 mg / mL solution. Before the test, it was diluted with water to 300 μg / mL and then sprayed on the test leaves.
[0266] The test bacteria is grape downy mildew. The test was conducted by the spore germination method on leaves. A spore suspension of grape downy mildew with a spore concentration of 105 spores / ml was inoculated on the back of grape leaves by spraying. The number of melon seedlings used in each test was about 30, and the melon seedlings were grown in sterilized compost. The melon plants inoculated with the melon powdery mildew spore suspension were placed in a high humidity environment for 24 hours, and then sprayed with 500μg / mL of the test solution. After 5 days, the antibacterial effect was evaluated using the same method as the potted antibacterial test of downy mildew mentioned above.
[0267] The inhibitory activity of the compounds against plant pathogens is shown in Table 1, the inhibition rate of the compounds against plant pathogens is shown in Table 2, and the control index of the compounds against melon powdery mildew and grape downy mildew is shown in Table 3.
[0268] Table 1 Inhibitory activity of compounds against plant pathogens
[0269]
[0270]
[0271] Table 2 Inhibition rate of compounds on plant pathogens
[0272]
[0273]
[0274] Table 3. Control index of compounds against melon powdery mildew and grape downy mildew*
[0275]
[0276]
[0277] From Tables 1 to 3, it can be seen that at a concentration of 75 μg / mL, most of the compounds showed high-efficiency and broad-spectrum inhibitory activity against all tested plant pathogens. At a concentration of 300 ppm, all tested compounds had significant protective effects against grape downy mildew and melon powdery mildew, and have potential use in the preparation of plant antibacterial drugs, and can be used as active ingredients or synergistic ingredients of plant antibacterial drugs.
[0278] Although the above embodiment describes the present invention in detail, it is only a part of the embodiments of the present invention, not all of the embodiments. Other embodiments can be obtained based on this embodiment without creativity, and these embodiments all fall within the protection scope of the present invention.
Claims
1. A 2,3-dibromopropionic acid ester compound, characterized in that: It has the structure shown in formula I-1, formula I-3 or formula I-3: The formula I-1 includes compound a, compound b or compound c; In the compound a, R is hydrogen, and R' is methyl, propyl, isopropyl or n-butyl; In the compound b, when R is hydrogen, 2-fluoro, 3-fluoro, 4-fluoro, 2-chloro, 3-chloro, 4-chloro, 2-bromo, 3-bromo, 4-bromo, 2-trifluoromethyl, 3-trifluoromethyl, 4-trifluoromethyl, 2-cyano, 3-cyano, 4-cyano, 2-nitro, 3-nitro, 4-nitro, 2-methyl, 3-methyl, 4-methyl, 2,3-difluoro, 2,4-difluoro, 2,5-difluoro, 2,6-difluoro, 3,4-difluoro, 3,5-difluoro, 2-fluoro-3-chloro, 2-fluoro-5-chloro, 2-fluoro-6-chloro, 3-fluoro-2-chloro, 3-fluoro-4-chloro, 5-fluoro-2-nitro, 5-chloro-2-nitro or 5-bromo-2-nitro, R' is ethyl; In compound c, when R is 2-methoxy, 3-methoxy or 4-ethyl, R' is ethyl.
2. The method for preparing the 2,3-dibromopropionic acid ester compound according to claim 1, characterized in that: When the 2,3-dibromopropionic acid ester compound is compound a, the preparation method comprises the following steps: After mixing cinnamic acid, dichloromethane and dichlorothionyl, a first substitution reaction is carried out, and the obtained reaction solution is mixed with an alcohol solution having a structure of formula A, and a second substitution reaction is carried out to obtain compound B; R'OH formula A; The compound B and the hydrobromic acid solution are dissolved in chloroform, and a first addition reaction is carried out under the initiation of tert-butyl hydroperoxide to obtain compound a; When the 2,3-dibromopropionic acid ester compound is compound b, the preparation method comprises the following steps: Ethyl 2-bromoacetate and triphenylphosphine are dissolved in ethyl acetate to carry out a nucleophilic substitution reaction to obtain compound C; The compound C and the benzaldehyde compound having the structure of formula D are dissolved in anhydrous ethanol, and subjected to a Wittig reaction to obtain a compound E; The compound E and the hydrobromic acid solution are dissolved in chloroform, and a second addition reaction is carried out under the initiation of tert-butyl hydroperoxide to obtain compound b; When the 2,3-dibromopropionic acid ester compound is compound c, the preparation method comprises the following steps: Dissolving the compound E and bromine in chloroform, and performing a third addition reaction to obtain compound c; When the 2,3-dibromopropionic acid ester compound is compound I-2 or I-3, the preparation method comprises the following steps: Dissolving the compound C and 2-pyridinecarboxaldehyde or 3-pyridinecarboxaldehyde in anhydrous ethanol, and performing a third substitution reaction to obtain a compound F; The compound F and bromine are dissolved in chloroform and subjected to a fourth addition reaction to obtain compound I-2 or I-3.
3. The preparation method according to claim 2, characterized in that: The molar ratio of the cinnamic acid to thionyl chloride is 1:1.5-3.0; the molar ratio of the cinnamic acid to alcohol is 1:1.4-2.0; The first substitution reaction is carried out at 40-50°C and the insulation time is 3-5h; The temperature of the second substitution reaction is room temperature, and the time is 2 to 3 hours.
4. The preparation method according to claim 2, characterized in that: The molar ratio of the compound B, the hydrobromic acid in the hydrobromic acid solution and tert-butyl hydroperoxide is 1:2-2.8:2-2.8; The temperature of the first addition reaction is 62-65° C., and the time is preferably 5-24 hours.
5. The preparation method according to claim 2, characterized in that: The molar ratio of ethyl 2-bromoacetate to triphenylphosphine is 1:1 to 1.
4.
6. The preparation method according to claim 2, characterized in that: The temperature of the nucleophilic substitution reaction is room temperature, and the time is 2 to 5 hours.
7. The preparation method according to claim 2, characterized in that: The molar ratio of the compound C to the benzaldehyde compound is 1:1-1.2; the temperature of the wittig reaction is 60-90° C.; and the insulation time is 2-4 hours.
8. The preparation method according to claim 2, characterized in that: The molar ratio of the compound E to bromine is 1:1.2-1.4; the temperature of the third addition reaction is 0-30°C; and the time is 2-5 hours.
9. Use of the 2,3-dibromopropionate compound according to claim 1 or the 2,3-dibromopropionate compound prepared by the preparation method according to any one of claims 2 to 8 as an antibacterial active ingredient in the preparation of plant antibacterial drugs.
10. The use according to claim 9, characterized in that The plant antibacterial drug has preventive and therapeutic effects on plant diseases caused by plant pathogenic fungi; the plant pathogenic fungi include one or more of melon powdery mildew, grape downy mildew, cotton wilt, watermelon wilt, potato dry rot, wheat fusarium, tomato early blight, cabbage black spot, tobacco brown spot, corn curvature, apple anthracnose, pumpkin wilt, apple rot, rice blast and apple ring rot.
